Back
Enphase Energy Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
36
ENPH
Enphase Energy
Last Price:
121.22
Seasonality Move:
13.86%
Sell
47
COLL
Collegium Pharmaceutical
Last Price:
34.17
Seasonality Move:
-8.9%
Sell
36
Enphase Energy (ENPH)
is a Sell
Is Enphase Energy a Buy, Sell or Hold?
- The current Enphase Energy [ENPH] share price is $121.23. The Score for ENPH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ENPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $34.18. The Score for COLL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENPH Stock Price Chart
What is Enphase Energy's stock price today?
-
The Enphase Energy share price today is $121.23
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENPH is experiencing slight buying pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $34.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing selling pressure, which indicates risk of future bearish movement.
ENPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.71 | Buy |
| Relative Strength Index (14 RSI): | 58.95 | Buy |
| Chaikin Money Flow: | 3972727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.03 - 115.75) | Buy |
| Bollinger Bands (100): | (107.59 - 123.63) | Buy |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 44.87 | Sell |
| Chaikin Money Flow: | -165525 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.51 - 37.27) | Sell |
| Bollinger Bands (100): | (32.8 - 38) | Sell |
ENPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.09 | Buy |
| 20-day SMA: | 112.52 | Buy |
| 50-day SMA: | 113.46 | Buy |
| 200-day SMA: | 114.54 | Buy |
| 8-day EMA: | 115.1 | Buy |
| 20-day EMA: | 113.73 | Buy |
| 50-day EMA: | 114.16 | Buy |
| 200-day EMA: | 125.85 | Sell |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.55 | Buy |
| 20-day SMA: | 35.44 | Sell |
| 50-day SMA: | 36.92 | Sell |
| 200-day SMA: | 29.87 | Buy |
| 8-day EMA: | 34.13 | Buy |
| 20-day EMA: | 34.97 | Sell |
| 50-day EMA: | 35.64 | Sell |
| 200-day EMA: | 31.38 | Buy |
Enphase Energy Earnings Growth & ENPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.28 per share, a decrease this year of $1.48 per share, and an increase next year of $2.20 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.70 per share.
Enphase Energy Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||